Studies sodium in the skin of adults with atopic dermatitis
Observes skin sodium, diet and skin barrier in adults aged 50 and older with eczema.
Key facts
- Who runs it
- University of California, San Francisco
- Where
- San Francisco, United StatesSee the 2 sites
- Trial code
- Registry title
- Sodium in the Skin and Atopic Dermatitis
- Status
- Recruiting
- People taking part
- 90 people, planned
- Started
- 12 May 2025
- Expected to end
- 30 Aug 2028
- Type of study
- Observational, 3 groups
- Record updated
- 14 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 50 and above, both healthy people and people with atopic dermatitis. They fill in questionnaires, give bio samples and have a sodium MRI scan.
- Age
- 50 years and above
- Sex
- All sexes
- Disease stage
- People with atopic dermatitis or healthy adults. Patients on dupilumab can join if they have taken it for at least two months and still meet the criteria for severe disease.
- Earlier treatment
- Cannot be having phototherapy or taking systemic atopic dermatitis medicines now, such as cyclosporine or methotrexate. Dupilumab is allowed after at least two months of use.
Main reasons for not taking part
- History of autoimmune disease
- Cardiac events in the last six months
- Impaired liver or kidney function (glomerular filtration rate <60ml/min)
- Current use of medicines that influence sodium excretion, or chemotherapy or antibiotic treatment
- Cannot have an MRI (for example a cardiac pacemaker, non-compatible intracranial vascular clips or pregnancy)
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Ages 50 years and above
- Willing to undergo non-contrast MRI (e.g., no contraindications to MRI, such as cardiac pacemakers, non-compatible intracranial vascular clips or pregnancy)
Who cannot take part
- Currently receiving phototherapy or taking systemic medications for atopic dermatitis including cyclosporine, methotrexate, or other broad immunosuppressive medications; (Patients on dupilumab will not be excluded if they have been on dupilumab for at least two months and still meet the criteria for severe disease.)
- History of autoimmune disease
- Cardiac events in the last six months
- Current use of medications that influence sodium excretion (e.g. thiazide diuretics, SGLT2 inhibitors and spironolactone), and/or chemotherapy or antibiotic treatment
- Impaired function of the liver or kidneys (glomerular filtration rate <60ml/min)
Where in United States
- San Francisco VA Medical CenterSan Francisco, United StatesContact: Frank Asare-Bediako, BSTaking people
- UCSF Mt Zion CampusSan Francisco, United StatesContact: Jie Zhu, MDTaking people
About the trial
What the trial wants to find out
The goal of this observational study is to understand factors associated with skin sodium storage in healthy adults and people with atopic dermatitis ages 50 and above.
Read full original descriptionShow less
The study is designed to test whether diet and skin barrier function are associated with skin sodium concentration and whether skin sodium concentration is linked to atopic dermatitis and immune profiles over time.
Participants will be asked to complete questionnaires, provide bio samples, and undergo non-contrast sodium MRI at 2-3 time points over 3-24 months.
The 3 groups in the trial
- No History of AD
Healthy controls
- Mild AD
Eczema Area Severity Index (EASI): scores \<7 will be considered mild AD
- Severe AD
Eczema Area Severity Index (EASI): scores \>21 will be considered severe
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Sodium in the Skin and Atopic Dermatitis
- Plain-language title
- Studies sodium in the skin of adults with atopic dermatitisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 14 July 2026